Recordation of Registered Items Changes: 30-Day Deadline and Common Omissions

1. Key takeaways

Filing of changed particulars looks simple and fails predictably. The deadline runs from the day the change occurs, and most late filings happen because nobody recorded that day.

• The deadline is 30 days from the date of change. Article 79 of the Registration and Filing Measures starts the clock at the day the change occurs and directs the filing to the original registering authority.
• A defined list enters the filing channel: the holder’s name and domicile, and the agent’s name and domicile, are filing items under Article 79 and do not go through variation registration.
• The penalty has two stages. Article 107 orders correction within a time limit, and only on expiry imposes a fine of CNY 10,000 to CNY 30,000; the first stage is a real opportunity.
• Product registration filing and production licence registration changes are separate tracks, the first within 30 days of the change, the second applied for within 30 working days and completed by the issuing authority within 5 working days (Production Measures, Article 16).
• Filing is not completion. Four linked actions follow: updating instructions and labels, reconciling UDI data, aligning online sales and distributor information, and updating internal records.
• Late filing has a concentrated cause: not ignorance of the rule, but failure to identify and record the date of change.

In our assessment, the difficulty is organisational rather than legal. Names and addresses sit with company secretarial, legal, administration and regulatory teams, so unless someone is told to raise the flag, the 30 days drain away. Set the internal notification window at 5 working days and write it into procedure.

2. Legal basis

Medical Device Supervision and Administration Regulations (State Council Order No. 739, promulgated 9 February 2021, effective 1 June 2021)

• Article 21: substantive changes to a registered product require variation registration; other changes are filed or reported as prescribed.

Medical Device Registration and Filing Measures (SAMR Order No. 47, promulgated 26 August 2021, effective 1 October 2021)

• Article 14, paragraph 2: an overseas applicant or filer shall designate an enterprise legal person within China as agent to handle registration and filing matters.
• Article 79: substantive changes require variation registration; other changes must be filed with the original registering authority within 30 days; the holder’s name and domicile and the agent’s name and domicile are filing items.
• Article 107: failure to file leads to an order to correct and, on expiry, a fine of CNY 10,000 to CNY 30,000.

Measures for the Supervision and Administration of Medical Device Production (SAMR Order No. 53, promulgated 10 March 2022, effective 1 May 2022)

• Article 15: a change of production address or an addition to the production scope requires a production licence variation.
• Article 16: a change to registered particulars must be applied for within 30 working days, and the issuing authority completes it within 5 working days of receipt.

Provisions on the Administration of Medical Device Instructions and Labels (former CFDA Order No. 6, promulgated 30 July 2014, effective 1 October 2014)

• Article 10(2) and Article 13(2): imported devices shall state the agent’s name, domicile and contact details in the instructions and on the label.
• Article 4: content shall be scientific, truthful, complete and accurate, consistent with the registered or filed content.
• Article 9: the text shall be in Chinese.
• Article 16: reviewed instructions may not be altered without authorisation.

Article 15 of the Unique Device Identification System Rules (NMPA, 2019) requires identifiers and related data to be uploaded before marketing. The Medical Device Online Sales Quality Management Specification (Announcement No. 46 of 2025, published 28 April 2025, effective 1 October 2025) governs online listing information.

Practical estimate. The rules do not define the date of change. Our approach is the point at which the registered particular takes legal effect: the date of the business licence change for a name, and the earlier of physical relocation or registration change for a domicile, with supporting documents attached to the filing.

Practical estimate. The exact scope and submission format follow the receiving department’s current requirements and the Annex to Announcement No. 121 of 2021. Not having received a notice is no defence for not filing.

3. Expert insights

The clock starts at the date of change, not at three common alternatives.

The second row is the common error: once an agent has completed its business registration change, weeks pass before the news reaches headquarters and the regulatory team, and most of the 30 days are gone. The fix is not a longer internal process but a shorter one, with a hard notification deadline and a single named owner.

Which matters are filed, and which are not.

The table solves the problem of one event triggering two tracks. If a domestic manufacturing entity changes its domicile, that may trigger both a filing against the product certificate and a licence particulars change, and the units differ, 30 days against 30 working days, so one does not substitute for the other.

The two-stage penalty leaves room to correct. Article 107 orders correction first and fines only on expiry, which means a company that receives an order still has a chance to file. Relying on that window is unwise: the order enters the supervisory record, and the compliance history outweighs the CNY 30,000 ceiling. Where several products share the same omission, several violations may be counted.

Six recurring omissions.

The last four are cases where the filing was made but the follow-through was not. They do not trigger Article 107, yet they leave the filing without effect.

4. Practical recommendations

• Write the identification of the date of change into procedure, covering the four change types, with a single owner and an internal notification window of 5 working days (practical estimate).
• Keep a filing ledger with two-way alerts, counting 30 days back from the change and running a second ledger at 30 working days where licence particulars are involved.
• Separate days from working days. Product filing runs on 30 days, licence particulars on 30 working days, and the earlier date governs the internal alert.
• Start the instruction and label revision in the same month, and decide how stock already on the market will be handled.
• Reconcile UDI data before marketing where identifier attributes are affected (Article 15).
• Update online listings and channel records, checking pages under Announcement No. 46 of 2025 and notifying distributors and hospitals to refresh supplier files.

5. Verification checklist

• □ The change is identified as a filing item: holder or agent name, domicile, or another non-substantive change.
• □ The date of change is recorded as the date it occurred, not the date of internal awareness or resolution.
• □ The filing was submitted to the original registering authority within 30 days of the change.
• □ No filing item was sent to variation registration, and no substantive change was sent to filing.
• □ Licence particulars, if affected, were applied for within 30 working days and completed within 5 working days (Article 16).
• □ A production address or scope change was identified as a licence variation, not a particulars change (Article 15).
• □ Evidence of the change is retained: licence amendment, relocation proof, updated authorisation.
• □ Chinese instructions are revised to the new details, stating the agent’s name, domicile and contact (Order No. 6, Article 10(2)).
• □ The smallest sales unit label is revised (Article 13(2)), in Chinese (Article 9).
• □ Treatment of stock already on the market is decided, with no mixing of old and new versions.
• □ UDI data was checked and updated before marketing (System Rules, Article 15).
• □ Online listings, distributor records and hospital supplier files are updated (Announcement No. 46 of 2025).
• □ The internal certificate register is updated so later renewals use current information.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Chinese market. Our team acts as the in-China registration agent, coordinates import agent and distributor arrangements, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com